Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma

Ann Surg Oncol. 2023 Aug 19. doi: 10.1245/s10434-023-14133-8. Online ahead of print.NO ABSTRACTPMID:37597079 | DOI:10.1245/s10434-023-14133-8

Source: Ann Oncol - August 19, 2023 Category: Cancer & Oncology Authors: Ashley M Holder Jennifer A Wargo Merrick I Ross Source Type: research